FDA Streamlines Compassionate Use Process for Experimental Treatments

The Food and Drug Administration has announced significant reforms to its compassionate use program, also known as expanded access, designed to accelerate patient access to experimental treatments for serious and… The post FDA Streamlines Compassionate Use Process for Experimental Treatments appeared first on herald.

Source: Hmetro